Apple researchers developed SimpleDesign an AI system that generates protein sequences and 3D structures together and could eventually help scientists design new drugs and useful proteins.
Bristol Myers Squibb is expanding its NVIDIA infrastructure with a Vera Rubin AI factory designed to support drug discovery, proprietary models, and AI-powered scientific research.
OpenAI’s new LifeSciBench benchmark was supposed to measure how useful AI can be in scientific research. Instead, it also highlights just how far today’s most advanced models still have to go before they can be trusted with real science.